How I treat pediatric venous thromboembolism

Blood. 2017 Sep 21;130(12):1402-1408. doi: 10.1182/blood-2017-04-742320. Epub 2017 Aug 3.

Abstract

The incidence of pediatric venous thromboembolism (VTE) has been increasing significantly over the past decade in part as a result of increased recognition of this serious disorder but more so because of the increased use of central venous catheters and other technological advancements involved in the care of ill children. Management of pediatric VTE is a complex undertaking, considering that the vast majority of children who develop this complication have serious underlying medical disorders. Although the incidence is rising, in comparison with adults, this remains a relatively rare disorder, and as such, large-scale clinical trials have not been completed, rendering management decisions to be based on extrapolation from adult data and the experience of the treating physician. Clearly, both are fraught with problems. Thus, day-to-day management remains more art than science until such time that the results from clinical trials (many of which are under way) become available. This edition of "How I Treat" describes the author's experience in managing 3 common scenarios that one may encounter in pediatric thrombosis and suggests a logical approach to such situations. Furthermore, the author provides 3 algorithms to help guide management decisions.

Publication types

  • Case Reports
  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Anticoagulants / therapeutic use
  • Child
  • Female
  • Humans
  • Infant, Newborn
  • Pulmonary Embolism / complications
  • Pulmonary Embolism / drug therapy
  • Venous Thromboembolism / complications
  • Venous Thromboembolism / drug therapy
  • Venous Thromboembolism / therapy*

Substances

  • Anticoagulants